Recent Patents on Anti-Infective Drug Discovery
Title:Patent Selections:
Volume: 7 Issue: 3
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Anti-Infective Drug Discovery 2012; 7 (3) . https://dx.doi.org/10.2174/157489112803521940
DOI https://dx.doi.org/10.2174/157489112803521940 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
10
Related Articles
-
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Silence of the Limbs: Pharmacological Symptomatic Treatment of Intermittent Claudication
Current Vascular Pharmacology Pharmacogenetics in Laboratory Diagnostics
Current Pharmacogenomics and Personalized Medicine Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets Fc-fusion Proteins in Therapy: An Updated View
Current Medicinal Chemistry Microbicides for Prevention of Transmission of Sexually Transmitted Diseases
Current Pharmaceutical Design Influence of Gold Nanoparticle Tagged Snake Venom Protein Toxin NKCT1 on Ehrlich Ascites Carcinoma (EAC) and EAC Induced Solid Tumor Bearing Male Albino Mice
Current Drug Delivery Outlines of the Biochemistry of Osteoarthritis
Current Rheumatology Reviews Muscle Atrophy Classification: The Need for a Pathway-Driven Approach
Current Pharmaceutical Design Patenting on Non Oral Anti-Allergic Drug
Recent Patents on Inflammation & Allergy Drug Discovery Relapsing Remitting Multiple Sclerosis and its Relationship with the Immune System and Oxidative Stress
Current Immunology Reviews (Discontinued) Microvascular Diseases: Is A New Era Coming?
Cardiovascular & Hematological Agents in Medicinal Chemistry Niacin Status, NAD Distribution and ADP-Ribose Metabolism
Current Pharmaceutical Design Protein Transduction Domains and their Utility in Gene Therapy
Current Gene Therapy Preface (Hot Topic: Regulatory Peptides Executive Editor: Dr. Nese Tuncel)
Current Pharmaceutical Design Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Meet Our Regional Editor
Protein & Peptide Letters Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Correlation between Potassium Channel Expression and Sensitivity to Drug-induced Cell Death in Tumor Cell Lines
Current Pharmaceutical Design